<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun R</submitter><funding>Purdue Center for Cancer Research</funding><funding>Susan G. Komen Breast Cancer Foundation</funding><funding>Purdue Institute for Drug Discovery (PIDD) Programmatic Area grant</funding><funding>Ralph W. and Grace M. Showalter Research Trust grant</funding><funding>NIGMS NIH HHS</funding><pagination>162</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8750214</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Leveraging the T cell immunity against tumors represents a revolutionary type of cancer therapy. 4-1BB is a well-characterized costimulatory immune receptor existing on activated T cells and mediating their proliferation and cytotoxicity under infectious diseases and cancers. Despite the accumulating interest in implementing 4-1BB as a therapeutic target for immune-related disorders, less is known about the pattern of its intracellular behaviors and regulations. It has been previously demonstrated that 4-1BB is heavily modified by &lt;i>N&lt;/i>-glycosylation; however, the biological importance of this modification lacks detailed elucidation. Through biochemical, biophysical, and cell-biological approaches, we systematically evaluated the impact of &lt;i>N&lt;/i>-glycosylation on the ligand interactio</pubmed_abstract><journal>Cells</journal><pubmed_title>&lt;i>N&lt;/i>-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization.</pubmed_title><pmcid>PMC8750214</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>R24 GM137782</funding_grant_id><funding_grant_id>CCR17488088</funding_grant_id><pubmed_authors>Kim AMJ</pubmed_authors><pubmed_authors>Sun R</pubmed_authors><pubmed_authors>Lim SO</pubmed_authors><pubmed_authors>Murray AA</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>N&lt;/i>-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization.</name><description>Leveraging the T cell immunity against tumors represents a revolutionary type of cancer therapy. 4-1BB is a well-characterized costimulatory immune receptor existing on activated T cells and mediating their proliferation and cytotoxicity under infectious diseases and cancers. Despite the accumulating interest in implementing 4-1BB as a therapeutic target for immune-related disorders, less is known about the pattern of its intracellular behaviors and regulations. It has been previously demonstrated that 4-1BB is heavily modified by &lt;i>N&lt;/i>-glycosylation; however, the biological importance of this modification lacks detailed elucidation. Through biochemical, biophysical, and cell-biological approaches, we systematically evaluated the impact of &lt;i>N&lt;/i>-glycosylation on the ligand interactio</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-04-08T06:49:28.557Z</modification><creation>2022-02-11T16:16:58.905Z</creation></dates><accession>S-EPMC8750214</accession><cross_references><pubmed>35011724</pubmed><doi>10.3390/cells11010162</doi></cross_references></HashMap>